Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 307.6B, Merck(MRK) trades at $123.98. The stock has a price-to-earnings ratio of 17.02 and currently yields dividends of 2.6%.
As of 2026-02-25, Merck(MRK) stock has fluctuated between $122.63 and $124.84. The current price stands at $123.98, placing the stock +1.1% above today's low and -0.7% off the high.
The Merck(MRK)'s current trading volume is 8.45M, compared to an average daily volume of 10.05M.
In the last year, Merck(MRK) shares hit a 52-week high of $124.84 and a 52-week low of $73.31.
In the last year, Merck(MRK) shares hit a 52-week high of $124.84 and a 52-week low of $73.31.
MRK News
Merck (NYSE:MRK) is restructuring its Human Health division into two units: Oncology and Specialty, Pharma & Infectious Diseases. The company has announced new...
RBC Capital initiated coverage of Merck (MRK) with an Outperform rating and $142 price target The firm sees the stock’s investor enthusiasm continuing with near...
On CNBC's “Halftime Report Final Trades,” Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, named Amazon.com, Inc. (NASDAQ:AMZN) as...
Analyst ratings
61%
of 31 ratingsMore MRK News
Merck (NYSE:MRK) plans to split its Human Health business into two divisions: one for oncology and one for specialty, pharma, and infectious diseases. The rest...
Merck & Co. Inc. (NYSE:MRK) shares are up during Monday’s premarket session as the company is evolving its Human Health organization to enhance commercial execu...
Feature Merck Creates Separate Cancer Business. The Stock Is Rising Ahead of Patent Cliff. In this article MRK SNY Merck’s blockbuster cancer treatment Keytruda...
Merck (MRK) announced changes in the structure of its Human Health organization. Merck is organizing its Human Health business into an Oncology Business Unit an...
Merck (MRK) is planning to split its human-health business into two divisions, one that will house its cancer drugs and the other will sell noncancer products,...
Keytruda is due to lose its U.S. patent protection in 2028. David Crosling/EPA-EFE/Shutterstock Merck MRK 0.33 %increase; green up pointing triangle is shaking...
The company might bend, but it won't break. Over the past year, Merck's (MRK +0.33%) shares have climbed by 46%. That seems a bit surprising. Last year, the co...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.